Digital Health Technologies In The GCC Market

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I have over a decade of experience as a healthcare and pharmaceutical consultant, working with multinational firms, regional players, and advisory platforms such as GLG, Guidepoint, and Atheneum.

My focus areas include market access, pricing and reimbursement, commercial strategy, and brand management across the Middle East, with a particular emphasis on the Gulf markets.

Q2. Which advanced digital health platforms and AI-driven analytics are shaping market access and regulatory approval pathways in GCC pharmaceutical markets?

Digital health platforms that integrate electronic health records, telemedicine, and e-prescription systems are transforming access across GCC. AI-driven analytics, particularly in pharmacovigilance and regulatory submissions, are enabling faster dossier reviews and real-time safety monitoring.

Saudi Arabia’s Wasfaty e-prescription platform and AI-enabled regulatory evaluation tools are notable examples of improving efficiency, transparency, and compliance.

Q3. What emerging opportunities does digital transformation present for enhancing market access, customer engagement, and commercial effectiveness?

Digital transformation allows companies to move beyond transactional sales toward continuous engagement. Advanced analytics, omnichannel marketing, and patient-support apps enhance adherence and experience. Market access is improved by predictive modeling of budget impact…